Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.56 - $16.15 $351,184 - $750,215
46,453 New
46,453 $721,000
Q4 2023

Feb 13, 2024

BUY
$4.9 - $12.86 $85,240 - $223,712
17,396 Added 103.97%
34,127 $409,000
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $117,117 - $188,391
16,731 New
16,731 $117,000
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $215,599 - $385,148
-5,233 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $309,531 - $481,383
5,233 New
5,233 $332,000
Q2 2021

Aug 12, 2021

SELL
$63.02 - $95.11 $550,416 - $830,690
-8,734 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$57.62 - $95.6 $503,253 - $834,970
8,734 New
8,734 $550,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.